Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

MDxHealth (MDXH) EBIT Margin (2021 - 2025)

Historic EBIT Margin for MDxHealth (MDXH) over the last 5 years, with Q3 2025 value amounting to 139.95%.

  • MDxHealth's EBIT Margin fell 86200.0% to 139.95% in Q3 2025 from the same period last year, while for Sep 2025 it was 142.31%, marking a year-over-year decrease of 123500.0%. This contributed to the annual value of 27.45% for FY2024, which is 114800.0% up from last year.
  • As of Q3 2025, MDxHealth's EBIT Margin stood at 139.95%, which was down 86200.0% from 139.26% recorded in Q2 2025.
  • In the past 5 years, MDxHealth's EBIT Margin registered a high of 221.72% during Q1 2022, and its lowest value of 152.02% during Q2 2022.
  • For the 5-year period, MDxHealth's EBIT Margin averaged around 142.53%, with its median value being 153.32% (2023).
  • Examining YoY changes over the last 5 years, MDxHealth's EBIT Margin showed a top increase of 3175800bps in 2023 and a maximum decrease of -652200bps in 2023.
  • Over the past 5 years, MDxHealth's EBIT Margin (Quarter) stood at 123.27% in 2021, then soared by 47bps to 181.48% in 2022, then decreased by -10bps to 163.15% in 2023, then fell by -12bps to 144.07% in 2024, then fell by -3bps to 139.95% in 2025.
  • Its EBIT Margin was 139.95% in Q3 2025, compared to 139.26% in Q2 2025 and 146.53% in Q1 2025.